LegoChem Biosciences, Inc. (141080.KQ)
KRW 96700.0
(-6.84%)
KRW 96700.0
(-6.84%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -80.82 Billion KRW | -48.26% |
| 2022 | -55.03 Billion KRW | -50.65% |
| 2021 | -36.53 Billion KRW | -15.24% |
| 2020 | -31.7 Billion KRW | -595.4% |
| 2019 | 6.39 Billion KRW | 134.2% |
| 2018 | -18.7 Billion KRW | -90.08% |
| 2017 | -9.84 Billion KRW | 3.25% |
| 2016 | -10.17 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -10.6 Billion KRW | -470.09% |
| 2024 Q1 | 2.86 Billion KRW | 111.03% |
| 2023 Q1 | -18.26 Billion KRW | 30.32% |
| 2023 Q2 | -16.95 Billion KRW | 7.18% |
| 2023 Q3 | -20.44 Billion KRW | -20.54% |
| 2023 Q4 | -25.94 Billion KRW | -26.91% |
| 2023 FY | -81.59 Billion KRW | -48.26% |
| 2022 Q1 | -9.26 Billion KRW | -472.89% |
| 2022 FY | -55.03 Billion KRW | -50.65% |
| 2022 Q3 | -10.43 Billion KRW | -14.37% |
| 2022 Q2 | -9.12 Billion KRW | 1.59% |
| 2022 Q4 | -26.21 Billion KRW | -151.35% |
| 2021 FY | -36.53 Billion KRW | -15.24% |
| 2021 Q3 | -9.55 Billion KRW | 0.0% |
| 2021 Q4 | 2.48 Billion KRW | 126.0% |
| 2020 FY | -31.7 Billion KRW | -595.4% |
| 2019 FY | 6.39 Billion KRW | 134.2% |
| 2018 FY | -18.7 Billion KRW | -90.08% |
| 2017 FY | -9.84 Billion KRW | 3.25% |
| 2016 FY | -10.17 Billion KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HLB Co., Ltd. | -125.02 Billion KRW | 35.355% |
| iNtRON Biotechnology, Inc. | -3.28 Billion KRW | -2360.376% |
| BINEX Co., Ltd. | 1.04 Billion KRW | 7854.504% |
| Bioneer Corporation | 791.75 Million KRW | 10308.027% |
| Anterogen.Co.,Ltd. | -5.07 Billion KRW | -1492.922% |
| MEDIPOST Co., Ltd. | -25.13 Billion KRW | -221.608% |
| CrystalGenomics, Inc. | -30.91 Billion KRW | -161.451% |
| Helixmith Co., Ltd | -35.24 Billion KRW | -129.313% |
| Chabiotech Co.,Ltd. | -9.42 Billion KRW | -757.514% |
| Medy-Tox Inc. | 17.32 Billion KRW | 566.579% |
| Peptron, Inc. | -15.6 Billion KRW | -417.995% |
| Amicogen, Inc. | 2.05 Billion KRW | 4030.779% |
| Genexine, Inc. | -41.24 Billion KRW | -95.976% |
| HLB Therapeutics Co.,Ltd. | -8.7 Billion KRW | -828.965% |
| ALTEOGEN Inc. | -9.73 Billion KRW | -730.068% |
| PharmaResearch Co., Ltd. | 100.81 Billion KRW | 180.167% |
| SillaJen, Inc. | -21.34 Billion KRW | -278.633% |
| JETEMA, Co., Ltd. | 2.63 Billion KRW | 3168.847% |
| OliX Pharmaceuticals,Inc | -18.18 Billion KRW | -344.437% |
| Genomictree Inc. | -17.3 Billion KRW | -367.087% |
| MedPacto, Inc. | -28.75 Billion KRW | -181.101% |
| D&D Pharmatech | -13.48 Billion KRW | -499.294% |
| EASY BIO,Inc. | 20.63 Billion KRW | 491.748% |
| GI Innovation, Inc. | -55.6 Billion KRW | -45.354% |